Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04263480
Title Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia (CZAR-1)
Acronym CZAR-1
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Christian Buske
Age Groups: adult | senior
Covered Countries DEU | AUT

No variant requirements are available.